Document is current
Any future updates will be listed below
-
Authors
Hernández-Díaz, Marta http://orcid.org/0000-0002-0056-3132
Rodríguez-González, Dara http://orcid.org/0000-0001-7594-0775
Heras-Recuero, Elena http://orcid.org/0009-0002-7703-3380
Gómez-Bernal, Fuensanta http://orcid.org/0000-0002-8597-1943
Quevedo-Abeledo, Juan Carlos http://orcid.org/0000-0003-0398-9072
González-Rivero, Agustín F. http://orcid.org/0000-0002-9712-6990
González-López, Elena
Ocejo-Vinyals, J. Gonzalo http://orcid.org/0000-0003-2245-4639
Jimenez-Sosa, Alejandro http://orcid.org/0000-0001-8732-2616
González-Gay, Miguel Ángel http://orcid.org/0000-0002-7924-7406
Ferraz-Amaro, Iván http://orcid.org/0000-0003-0197-5267
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PI20/00084)
- License Information
-
More Information
Article History
Received: 6 May 2024
Accepted: 1 July 2024
First Online: 8 July 2024
Declarations
:
: The study protocol was approved by the institutional review committees at Hospital Universitario de Canarias and Hospital Universitario Doctor Negrín, and all subjects provided written informed consent.
: Not applicable.
: The authors declare that they have no competing interests related to this study. Nevertheless, Professor MA Gonzalez-Gay and Dr. Iván Ferraz-Amaro would like to acknowledge that they have received grants/research supports from Abbott, MSD, Jansen and Roche, as well as consultation fees from company-sponsored speakers bureaus associated with Abbott, Pfizer, Roche, Sanofi, Celgene and MSD.
